Vanguard Group’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$3.26B Sell
49,074,378
-381,665
-0.8% -$24.7M 0.05% 351
2025
Q3
$3.33B Buy
49,456,043
+1,133,638
+2% +$89.7M 0.05% 345
2025
Q2
$4.22B Buy
48,322,405
+866,506
+2% +$67.9M 0.07% 284
2025
Q1
$3.24B Buy
47,455,899
+925,882
+2% +$75.6M 0.06% 326
2024
Q4
$3.62B Sell
46,530,017
-904,784
-2% -$67M 0.06% 300
2024
Q3
$3.18B Buy
47,434,801
+921,617
+2% +$75.7M 0.06% 330
2024
Q2
$5.27B Buy
46,513,184
+1,909,439
+4% +$241M 0.1% 171
2024
Q1
$6.19B Buy
44,603,745
+136,282
+0.3% +$17.1M 0.12% 144
2023
Q4
$5.52B Buy
44,467,463
+278,458
+0.6% +$28.4M 0.12% 151
2023
Q3
$4.12B Sell
44,189,005
-94,986
-0.2% -$10.7M 0.1% 188
2023
Q2
$5.69B Buy
44,283,991
+171,858
+0.4% +$20.8M 0.13% 133
2023
Q1
$5.12B Buy
44,112,133
+292,297
+0.7% +$32.7M 0.13% 135
2022
Q4
$4.96B Buy
43,819,836
+137,410
+0.3% +$15.1M 0.14% 140
2022
Q3
$3.52B Buy
43,682,426
+511,557
+1% +$43.3M 0.1% 194
2022
Q2
$3.22B Buy
43,170,869
+967,733
+2% +$88.3M 0.09% 228
2022
Q1
$5.4B Buy
42,203,136
+561,860
+1% +$61.5M 0.13% 135
2021
Q4
$5.59B Buy
41,641,276
+244,244
+0.6% +$35.1M 0.13% 138
2021
Q3
$5.66B Buy
41,397,032
+373,664
+0.9% +$47.1M 0.14% 118
2021
Q2
$4.38B Buy
41,023,368
+74,356
+0.2% +$7.14M 0.11% 165
2021
Q1
$3.68B Buy
40,949,012
+20,032
+0% +$1.88M 0.1% 181
2020
Q4
$3.78B Sell
40,928,980
-603,660
-1% -$53.9M 0.11% 162
2020
Q3
$4.28B Buy
41,532,640
+430,248
+1% +$45M 0.14% 122
2020
Q2
$4.17B Buy
41,102,392
+6,127,540
+18% +$548M 0.15% 120
2020
Q1
$2.35B Buy
34,974,852
+1,105,912
+3% +$68.8M 0.1% 185
2019
Q4
$1.85B Buy
33,868,940
+278,776
+0.8% +$13.2M 0.06% 339
2019
Q3
$1.25B Buy
33,590,164
+755,944
+2% +$29.4M 0.05% 445
2019
Q2
$1.23B Sell
32,834,220
-1,679,932
-5% -$52.8M 0.05% 440
2019
Q1
$1.03B Sell
34,514,152
-76,100
-0.2% -$2.67M 0.04% 494
2018
Q4
$1.04B Buy
34,590,252
+2,818,808
+9% +$89.4M 0.05% 452
2018
Q3
$1.14B Buy
31,771,444
+3,264,988
+11% +$101M 0.04% 465
2018
Q2
$677M Sell
28,506,456
-88,108
-0.3% -$1.87M 0.03% 635
2018
Q1
$530M Buy
28,594,564
+617,912
+2% +$9.14M 0.02% 727
2017
Q4
$401M Buy
27,976,652
+213,692
+0.8% +$2.78M 0.02% 862
2017
Q3
$340M Buy
27,762,960
+478,552
+2% +$8.46M 0.02% 934
2017
Q2
$499M Buy
27,284,408
+899,232
+3% +$16.6M 0.02% 703
2017
Q1
$559M Buy
26,385,176
+1,054,172
+4% +$20.6M 0.03% 646
2016
Q4
$378M Buy
25,331,004
+2,119,188
+9% +$37.5M 0.02% 784
2016
Q3
$509M Buy
23,211,816
+539,556
+2% +$12M 0.03% 623
2016
Q2
$450M Buy
22,672,260
+955,896
+4% +$16.3M 0.03% 650
2016
Q1
$369M Buy
21,716,364
+749,868
+4% +$12.5M 0.02% 710
2015
Q4
$429M Buy
20,966,496
+738,832
+4% +$15.4M 0.03% 642
2015
Q3
$434M Buy
20,227,664
+578,732
+3% +$12.9M 0.03% 618
2015
Q2
$393M Buy
19,648,932
+678,424
+4% +$11.9M 0.03% 696
2015
Q1
$296M Buy
18,970,508
+1,021,716
+6% +$15.4M 0.02% 825
2014
Q4
$247M Buy
17,948,792
+515,296
+3% +$6.31M 0.02% 854
2014
Q3
$174M Buy
17,433,496
+49,052
+0.3% +$501K 0.01% 1020
2014
Q2
$172M Sell
17,384,444
-263,600
-1% -$2.34M 0.01% 1053
2014
Q1
$182M Buy
17,648,044
+1,526,176
+9% +$15.8M 0.02% 971
2013
Q4
$143M Buy
16,121,868
+691,592
+4% +$5.47M 0.01% 1089
2013
Q3
$109M Buy
15,430,276
+282,296
+2% +$1.79M 0.01% 1177
2013
Q2
$85M Buy
+15,147,980
New +$72.6M 0.01% 1277

Other funds holding DXCM